Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Double-blind RCT comparing 15 mg versus 30 mg Toradol on postoperative pain in orthopedic and ENT surgery
2012-003685-40Phase 4Terminated
- Sponsor
- Rigshospitalet
- Start
- Oct 2012
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of ketorolac in postoperative pain (2 arms), sponsored by Rigshospitalet. Primary endpoint: Postoperative pain VAS score. Started Oct 2012; status: terminated.
02
Drugs
ketorolac
03
Conditions
postoperative pain
Beyond the preview
Go deeper on 2012-003685-40.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2012-003685-40.